Leerink Report: About 900 Next-Gen Sequencers Deployed to Date; Market Poised for Growth
June 30, 2009
Leerink Report: About 900 Next-Gen Sequencers Deployed to Date; Market Poised for Growth
The reports note that Illumina's Genome Analyzer currently accounts for about two-thirds of next-gen sequencing systems housed at 15 international genome centers, though smaller labs tend to have a "far more equitable" split between Illumina's GA, Applied Biosystems' SOLiD, and 454 Life Sciences's GS FLX.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- New Sequencing Platforms Drive Choice, Competition, Lawsuits in 2010
January 4, 2011 / In Sequence - Survey Finds MiSeq, Ion PGM Tied for Most Likely Sequencing Purchase over Next 12 Months
April 24, 2012 / In Sequence - IOM Workshop Discusses Interim Strategies to Handle Unresolved Challenges of Clinical Sequencing
July 27, 2011 / Clinical Sequencing News - Court Orders Mediation Conference in Helicos Patent Suit Against PacBio, Life Tech, Illumina
July 26, 2011 / In Sequence - Paired Ends
July 19, 2011 / In Sequence